Share This! Tweet This! Recommend Us! Print Page

Pediatric Clinical Trials

haley and dr irwin

Bone

AEWS1221

Randomized Phase 2 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma 

Protocol Summary

Brain

ACNS0831

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years

Protocol Summary

ACNS1422

A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients

Protocol Summary

Gastrointestinal

-None at this time-

Genitourinary

AREN03B2

Renal Tumors Classification, Biology, and Banking Study

Protocol Summary

Germ Cell

AGCT1531

A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Protocol Summary

Head & Neck

ANBL1232

Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma

Protocol Summary

Hematology

ANHL12P1

A Randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, Commercially Labeled) in Combination With Chemotherapy for Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL) IND # 117117

Protocol Summary

AAML1331

A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid

Protocol Summary

Lymphoma

AHOD1331

A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults

Protocol Summary

Other

ACCL15N1CD

Use of Evidence-Based Supportive Care Clinical Practice Guidelines in Pediatric Oncology

Protocol Summary

APEC14B1

The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

Protocol Summary

ALTE05N1

Umbrella Long-Term Follow-Up Protocol

Protocol Summary

ANBL00B1

Neuroblastoma Biology Studies

Protocol Summary